Early Chimeric Antigen Receptor T Cell Expansion Is Associated with Prolonged Progression-Free Survival for Patients with Relapsed/Refractory Multiple Myeloma Treated with Ide-Cel: A Retrospective Monocentric Study
Léo Caillot, Emmanuel Sleiman, Ingrid Lafon, Marie‐Lorraine Chrétien, Pauline Gueneau, Alexandre Payssot, Romain Pedri, Daniela Lakomy, François Bailly, Julien Guy, Jean‐Pierre Quenot, Hervé Avet‐Loiseau, Denis Caillot
Topics & Concepts
Chimeric antigen receptorRefractory (planetary science)MedicineMultiple myelomaProgression-free survivalAntigenOncologyCancer researchInternal medicineOverall survivalImmunologyImmunotherapyBiologyCancerAstrobiologyCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors